Shijie Shen

Title: The Innovative Contributions of Inventor Shijie Shen

Introduction

Shijie Shen, an accomplished inventor based in Beijing, China, has made significant strides in the field of biotechnology. With a focus on developing novel therapeutic solutions, he has obtained a patent for his groundbreaking work in monoclonal antibodies, contributing to advancements in medical science.

Latest Patents

Shijie Shen holds a notable patent titled "Anti-human IL-17 monoclonal antibodies and use thereof". This patent presents a novel anti-human IL-17 monoclonal antibody derived from phage antibody library screening and genetic engineering. The invention encompasses the antibody, functional fragments, polynucleotides encoding the monoclonal antibody, vectors, host cells, and methods for preparation and purification, highlighting its potential applications in therapeutic settings.

Career Highlights

Throughout his career, Shijie Shen has worked for prominent biotech firms, including Beijing Bettermab Biotechnology Co., Ltd and Beijing Wisdomab Biotechnology Co., Ltd. His work in these organizations has been instrumental in pushing the boundaries of research and innovation in the biotechnology sector.

Collaborations

Shijie Shen has collaborated with esteemed colleagues such as Zhigang Liu and Yulan Liu. These partnerships have fostered an environment of creativity and innovation, allowing for comprehensive research and development of advanced medical therapies.

Conclusion

Shijie Shen's contributions as an inventor have established him as a pivotal figure in the field of biotechnology. His patent for anti-human IL-17 monoclonal antibodies exemplifies his dedication to improving healthcare through innovative solutions. As research continues to evolve, the impact of his work is poised to make a lasting difference in therapeutic applications.